These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 25918978)

  • 1. Solubility of chiral species as function of the enantiomeric excess.
    Coquerel G
    J Pharm Pharmacol; 2015 Jun; 67(6):869-78. PubMed ID: 25918978
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chiral ionic liquid that functions as both solvent and chiral selector for the determination of enantiomeric compositions of pharmaceutical products.
    Tran CD; Oliveira D; Yu S
    Anal Chem; 2006 Feb; 78(4):1349-56. PubMed ID: 16478133
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Resolution of chiral molecules of pharmaceutical interest by means of preferential crystallization].
    Coquerel G
    Ann Pharm Fr; 2009 Jul; 67(4):256-64. PubMed ID: 19596099
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fluorescence determination of enantiomeric composition of pharmaceuticals via use of ionic liquid that serves as both solvent and chiral selector.
    Tran CD; Oliveira D
    Anal Biochem; 2006 Sep; 356(1):51-8. PubMed ID: 16860773
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural Aspects of Solid Solutions of Enantiomers.
    Brandel C; Petit S; Cartigny Y; Coquerel G
    Curr Pharm Des; 2016; 22(32):4929-4941. PubMed ID: 27510486
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The construction, prediction and measurement of co-crystal ternary phase diagrams as a tool for solvent selection.
    Holaň J; Stěpánek F; Billot P; Ridvan L
    Eur J Pharm Sci; 2014 Oct; 63():124-31. PubMed ID: 24995701
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Solubility of molecular crystals: polymorphism in the light of solubility theory.
    Bennema P; van Eupen J; van der Wolf BM; Los JH; Meekes H
    Int J Pharm; 2008 Mar; 351(1-2):74-91. PubMed ID: 17980982
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prediction of pharmaceutical solubility Via NRTL-SAC and COSMO-SAC.
    Tung HH; Tabora J; Variankaval N; Bakken D; Chen CC
    J Pharm Sci; 2008 May; 97(5):1813-20. PubMed ID: 17786984
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enantiomeric 3-chloromandelic acid system: binary melting point phase diagram, ternary solubility phase diagrams and polymorphism.
    Le Minh T; von Langermann J; Lorenz H; Seidel-Morgenstern A
    J Pharm Sci; 2010 Sep; 99(9):4084-95. PubMed ID: 20575001
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Separation of chiral pharmaceutical drugs by chromatographic and electrophoretic techniques].
    Morin P
    Ann Pharm Fr; 2009 Jul; 67(4):241-50. PubMed ID: 19596097
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rationalization and prediction of solution enantiomeric excess in ternary phase systems.
    Klussmann M; White AJ; Armstrong A; Blackmond DG
    Angew Chem Int Ed Engl; 2006 Dec; 45(47):7985-9. PubMed ID: 16986192
    [No Abstract]   [Full Text] [Related]  

  • 12. Modeling and prediction of cocrystal phase diagrams.
    Ainouz A; Authelin JR; Billot P; Lieberman H
    Int J Pharm; 2009 Jun; 374(1-2):82-9. PubMed ID: 19446763
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rational coformer or solvent selection for pharmaceutical cocrystallization or desolvation.
    Abramov YA; Loschen C; Klamt A
    J Pharm Sci; 2012 Oct; 101(10):3687-97. PubMed ID: 22821740
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Purification method development for chiral separation in supercritical fluid chromatography with the solubilities in supercritical fluid chromatographic mobile phases.
    Gahm KH; Tan H; Liu J; Barnhart W; Eschelbach J; Notari S; Thomas S; Semin D; Cheetham J
    J Pharm Biomed Anal; 2008 Apr; 46(5):831-8. PubMed ID: 17531426
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Crystal engineering of active pharmaceutical ingredients to improve solubility and dissolution rates.
    Blagden N; de Matas M; Gavan PT; York P
    Adv Drug Deliv Rev; 2007 Jul; 59(7):617-30. PubMed ID: 17597252
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Solubility prediction, solvate and cocrystal screening as tools for rational crystal engineering.
    Loschen C; Klamt A
    J Pharm Pharmacol; 2015 Jun; 67(6):803-11. PubMed ID: 25851032
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of the solvent in the adsorption-desorption equilibrium of cinchona alkaloids between solution and a platinum surface: correlations among solvent polarity, cinchona solubility, and catalytic performance.
    Ma Z; Zaera F
    J Phys Chem B; 2005 Jan; 109(1):406-14. PubMed ID: 16851030
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Solid-Phase and Oscillating Solution Crystallization Behavior of (+)- and (-)-N-Methylephedrine.
    Tulashie SK; Polenske D; Seidel-Morgenstern A; Lorenz H
    J Pharm Sci; 2016 Nov; 105(11):3359-3365. PubMed ID: 27659160
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recent advances in SPE-chiral-HPLC methods for enantiomeric separation of chiral drugs in biological samples.
    Ali I; Alam SD; Al-Othman ZA; Farooqi JA
    J Chromatogr Sci; 2013 Aug; 51(7):645-54. PubMed ID: 23377648
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enantiomeric purity of chiral derivatizing reagents for enantioresolution.
    Bhushan R
    Bioanalysis; 2011 Sep; 3(18):2057-60. PubMed ID: 21942516
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.